| Net Loss per Share Attributable to Common Stockholders |
(12) Net
Loss per Share Attributable to Common Stockholders The
following table sets forth the computation of the basic and diluted net loss
per share:
| | | | | | | | | |
|
|
Three Months Ended March 31,
|
|
| |
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
Net loss attributable to common stockholders, basic & diluted
|
|
$
|
(5,896,839 |
)
|
|
|
(3,599,510 |
)
|
| |
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in computing net loss per share attributable to common stockholders,
basic and diluted
|
|
|
25,149,236 |
|
|
|
21,775,357 |
|
|
Net loss per share attributable to common stockholders, basic and diluted
|
|
$
|
(0.23 |
)
|
|
|
(0.17 |
)
|
The following
potentially dilutive securities have been excluded from the computations of
diluted weighted average shares outstanding because they would be
anti-dilutive:
| | | | | | | | | |
| |
|
March 31,
2025
|
|
|
March 31,
2024
|
|
|
Options to purchase common stock
|
|
|
4,538,059 |
|
|
|
2,998,233 |
|
|
Warrants to purchase common stock, in connection with April 2023 financing
|
|
|
68,809 |
|
|
|
68,809 |
|
|
Warrants to purchase common stock, in connection with November 2023 financing
|
|
|
5,805,083 |
|
|
|
11,610,166 |
|
|
Warrants to purchase common stock
|
|
|
196,816 |
|
|
|
201,578 |
|
|
Total potential shares
|
|
|
10,608,767 |
|
|
|
14,878,786 |
|
|